Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · IEX Real-Time Price · USD
12.38
+0.07 (0.57%)
At close: Jul 19, 2024, 4:00 PM
12.39
+0.01 (0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
TCMD Revenue
Tactile Systems Technology had revenue of $276.67M in the twelve months ending March 31, 2024, with 7.38% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $61.09M with 3.81% year-over-year growth. In the year 2023, Tactile Systems Technology had annual revenue of $274.42M with 11.20% growth.
Revenue (ttm)
$276.67M
Revenue Growth
+7.38%
P/S Ratio
1.06
Revenue / Employee
$278,896
Employees
992
Market Cap
294.18M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 274.42M | 27.64M | 11.20% |
Dec 31, 2022 | 246.79M | 38.73M | 18.61% |
Dec 31, 2021 | 208.06M | 20.93M | 11.18% |
Dec 31, 2020 | 187.13M | -2.36M | -1.25% |
Dec 31, 2019 | 189.49M | 45.74M | 31.82% |
Dec 31, 2018 | 143.75M | 34.47M | 31.54% |
Dec 31, 2017 | 109.28M | 24.74M | 29.26% |
Dec 31, 2016 | 84.54M | 21.67M | 34.47% |
Dec 31, 2015 | 62.87M | 15.14M | 31.71% |
Dec 31, 2014 | 47.74M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AngioDynamics | 324.01M |
Alimera Sciences | 90.22M |
Poseida Therapeutics | 82.50M |
SOPHiA GENETICS | 64.18M |
Aquestive Therapeutics | 51.50M |
Adaptimmune Therapeutics | 18.36M |
Verrica Pharmaceuticals | 8.91M |
Orchestra BioMed Holdings | 2.22M |
TCMD News
- 2 months ago - Tactile Medical to Present at the William Blair 44th Annual Growth Stock Conference - GlobeNewsWire
- 2 months ago - Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue - GlobeNewsWire
- 3 months ago - Tactile Medical to Release First Quarter of Fiscal Year 2024 Financial Results on May 6, 2024 - GlobeNewsWire
- 5 months ago - Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook - GlobeNewsWire
- 5 months ago - Tactile Medical to Participate in Upcoming Investor Conferences in February and March - GlobeNewsWire
- 6 months ago - Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024 - GlobeNewsWire
- 9 months ago - Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook - GlobeNewsWire